The cell proliferation index, Ki-67 labeling index (LI) indicates the status of cell proliferation activity which corresponds with tumor biological behavior, treatment efficacy and prognosis. If the preoperative Ki-67 expression status in HCC can be accurately predicted noninvasively, it may provide important information for clinical decision-making. T1 mapping is useful for preoperative prediction of Ki-67 LI of HCC. The nomogram Combining T1 mapping on gadoxetic acid-enhanced MRI and clinical indicators has good predictive efficacy for preoperative prediction of Ki-67 LI, which can promote the individualized risk stratification and further treatment decision of HCC patients.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: